Evaluating the burden of poor glycemic control associated with therapeutic inertia in patients with type 2 diabetes in the UK.
Conclusions: The economic burden of poor glycemic control in type 2 diabetes in the UK is substantial. Efforts to avoid clinical inertia could substantially reduce diabetes-related complication costs even in the short-term.
PMID: 31311364 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
More News: Databases & Libraries | Diabetes | Diabetes Type 2 | Economics | Endocrinology | Health Management | Primary Care | Study